Brain Disease Device And Software Market to Grow at a CAGR of 10.1% from 2025 to 2029
Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Are The Growth Projections For The Brain Disease Device And Software Market Size During 2025–2029?
The brain disease device and software market has witnessed rapid growth in recent years. It is anticipated to expand from $14.11 billion in 2024 to $15.59 billion in 2025, achieving a compound annual growth rate (CAGR) of 10.5%. This historical growth can be attributed to factors such as the increasing occurrence of neurological disorders, greater understanding of the benefits of early diagnosis and treatment for brain diseases, a rising demand for non-invasive diagnostic tools, expanding government investments in healthcare infrastructure, and a growing patient preference for home-based neurological monitoring.
The brain disease device and software market is poised for significant expansion in the coming years. Projections indicate it will reach $22.94 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 10.1%. This expansion during the forecast period is primarily driven by an increasing need for tailored brain disease management options, the expanding utilization of cloud-based platforms for analyzing brain health data, a heightened emphasis on remote patient monitoring and telehealth services, the growing presence of smartphones and mobile applications within healthcare, and the wider acceptance of digital therapeutics for cognitive conditions. Key developments anticipated in this period encompass the incorporation of wearable brain monitoring technologies, enhancements in neurostimulation devices, the creation of closed-loop neurostimulation systems, improvements in imaging technologies, and advancements in neuroimaging methodologies.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27230&type=smp
Which Factors And Drivers Are Influencing The Brain Disease Device And Software Market In 2025?
The rising occurrence of neurological conditions is anticipated to drive the expansion of the brain disease device and software market. These disorders are health issues impacting the brain, spinal cord, and nerves, resulting in various symptoms like cognitive, motor, and sensory difficulties. The growing incidence of neurological disorders is connected to the world’s aging populace, given that aging progressively hinders neuronal activity, diminishes brain plasticity, and heightens oxidative stress, all of which fuel the emergence and advancement of these conditions. Tools and programs for brain diseases aid in managing neurological disorders through facilitating early detection and constant oversight. They assist in prompt intervention by utilizing advanced AI and data analytics, thereby enhancing patient care and the effectiveness of treatments. For example, data from July 2024, released by the UK-based government agency National Health Service, indicated 487,432 patients had been diagnosed with dementia (a progressive brain disorder affecting memory, thinking, and daily activities) by June 30, 2024, which marked an increase of 3,155 cases from May 31, 2024. Consequently, the expanding occurrence of neurological disorders is propelling the growth of the brain disease device and software market.
What Are The Segment Types Shaping The Brain Disease Device And Software Market?
The brain disease device and software market covered in this report is segmented
1) By Type: Brain Disease Device, Brain Disease Software
2) By Technology: Wearable Technology, Telemedicine Solutions, Artificial Intelligence And Machine Learning, Mobile Health Applications, Neuroimaging Technologies
3) By Application: Alzheimer’s Disease, Parkinson’s Disease, Epilepsy, Other Applications
4) By End-User: Hospitals And Clinics, Home Care Settings, Rehabilitation Centers, Research and Academic Institutions, Diagnostic Laboratories
Subsegments:
1) By Brain Disease Device: Neurostimulation Devices, Brain Imaging Devices, Brain Monitoring Devices, Brain-Computer Interface Devices, Neurorehabilitation Devices
2) By Brain Disease Software: Brain Imaging Analysis Software, Cognitive Assessment Software, Neurofeedback Software, Brain Data Management Software, Neurological Disorder Diagnostic Software
Which Ongoing Trends Are Expected To Shape The Brain Disease Device And Software Market Outlook?
Major companies operating in the brain disease device and software market are concentrating on developing novel solutions, such as digital healthcare platforms, to improve early diagnosis and enhance the management of neurological disorders. Digital healthcare solutions refer to technology-driven tools and systems that employ software, connected devices, and data analytics to support the prevention, diagnosis, monitoring, and treatment of various health conditions, including neurological disorders. For instance, in July 2022, Linus Health Inc., a US-based digital health company, launched an iPad-based brain health platform aimed at enabling the early detection of Alzheimer’s disease and other dementias in primary care settings. This platform incorporates digital cognitive assessments and AI-driven analytics to furnish clinicians with actionable insights, thereby facilitating earlier intervention and personalized care plans. It seeks to improve the accessibility and efficiency of identifying cognitive decline at its nascent stages by integrating seamlessly into routine primary care visits. This innovation underscores the growing emphasis on digital tools to transform neurological care, offering scalable and precise methods for detecting and managing brain health conditions.
Who Are The Core Companies Influencing The Brain Disease Device And Software Market Landscape?
Major companies operating in the brain disease device and software market are Medtronic plc, Insightec Ltd., Cadwell Industries Inc., NeuroPace Inc., Synchron Inc., Compumedics Ltd., Neuronetics Inc., BrainsWay Ltd., The Magstim Company Ltd., Paradromics Inc., Linus Health Inc., MagVenture A/S, Neurophet Inc., Neuroelectrics Corporation, BrainScope Company Inc, Blackrock Neurotech LLC, Neurable Inc., NeuroSigma Inc., Cognixion Inc., Brightmind.AI.
Download The Full Report For Exclusive Market Findings:
Which Geographies Are Emerging As Strong Markets For The Brain Disease Device And Software Industry?
North America was the largest region in the brain disease device and software market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brain disease device and software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Brain Disease Device And Software Market Report:
https://www.thebusinessresearchcompany.com/customise?id=27230&type=smp
Browse Through More Reports Similar to the Global Brain Disease Device And Software Market 2025, By The Business Research Company
Industrial Insulation Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/industrial-insulation-global-market-report
Building Insulation Materials Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/building-insulation-materials-global-market-report
Technical Insulation Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/technical-insulation-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.